12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Company News  |  Deals

Pfizer, QB3 deal

Pfizer's External R&D Innovation (ERDI) center and QB3 extended by three years through 2014 a 2008 partnership under which the pharma can partner with researchers in QB3's...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >